يعرض 1 - 10 نتائج من 1,024 نتيجة بحث عن '"кесарево сечение"', وقت الاستعلام: 0.72s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المصدر: Meditsinskiy sovet = Medical Council; № 4 (2024); 48-55 ; Медицинский Совет; № 4 (2024); 48-55 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    العلاقة: https://www.med-sovet.pro/jour/article/view/8174/7202Test; Kiesler ZG, Hunter MI, Balboula AZ, Patterson AL. Periostin’s role in uterine leiomyoma development: a mini-review on the potential periostin poses as a pharmacological intervention for uterine leiomyoma. Arch Gynecol Obstet. 2024. https://doi.org/10.1007/s00404-024-07435-zTest.; Koga K, Fukui M, Fujisawa M, Suzukamo Y. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey). J Obstet Gynaecol Res. 2023;49(10):2528–2537. https://doi.org/10.1111/jog.15758Test.; El Sabeh M, Borahay MA. The Future of Uterine Fibroid Management: a More Preventive and Personalized Paradigm. Reprod Sci. 2021;28(11):3285–3288. https://doi.org/10.1007/s43032-021-00618-yTest.; Nieh C, Mabila SL. Incidence and health care burden of uterine fibroids among female service members in the active component of the U.S. Armed Forces, 2011–2022. MSMR. 2024;31(2):9–15. Available at: https://europepmc.org/article/MED/38466970Test.; Камхен ВБ, Жаймырзаева ГА. Миома матки у женщин фертильного возраста: размеры узлов и клинические проявления. Вестник КазНМУ. 2020;(3):12–14. Режим доступа: https://cyberleninka.ru/article/n/miomamatki-u-zhenschin-fertilnogo-vozrasta-razmery-uzlov-i-klinicheskieproyavleniyaTest.; Michos G, Dagklis T, Papanikolaou E, Tsakiridis I, Oikonomou K, Mamopoulos AM et al. Uterine Leiomyomas and Infertility: A Comparison of National and International Guidelines. Cureus. 2023;15(12):e50992. https://doi.org/10.7759/cureus.50992Test.; Ahmad A, Kumar M, Bhoi NR, Badruddeen, Akhtar J, Khan MI et al. Diagnosis and management of uterine fibroids: current trends and future strategies. J Basic Clin Physiol Pharmacol. 2023;34(3):291–310. https://doi.org/10.1515/jbcpp-2022-0219Test.; Cianci S, Gulino FA, Palmara V, La Verde M, Ronsini C, Romeo P et al. Exploring Surgical Strategies for Uterine Fibroid Treatment: A Comprehensive Review of Literature on Open and Minimally Invasive Approaches. Medicina (Kaunas). 2023;60(1):64. https://doi.org/10.3390/medicina60010064Test.; Ordás P, Spagnolo E, Fernández LG, Diestro Tejeda MD, Lafuente P, Salas P et al. Comparison of surgical and obstetric outcomes in women with uterine leiomyomas after laparoscopic vs. abdominal myomectomy: A singlecenter cohort study. Front Surg. 2022;9:997078. https://doi.org/10.3389/fsurg.2022.997078Test.; Tossamartvorakul M, Mendoza MCVR, Huang KG, Chang SH. Metastatic Smooth Muscle Tumor of Uncertain Malignant Potential after Laparoscopic Presuming Myomectomy. Gynecol Minim Invasive Ther. 2021;10(3):187–190. https://doi.org/10.4103/GMIT.GMIT_44_20Test.; Kociuba J, Łoziński T, Latra K, Korczyńska L, Skowyra A, Zarychta E, Ciebiera M. Occurrence and Risk Factors for Perioperative Treatment Discontinuation during Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MR-HIFU) Therapy in Symptomatic Uterine Fibroids-A Retrospective CaseControl Study. J Clin Med. 2023;12(18):5999. https://doi.org/10.3390/jcm12185999Test.; Akhatova A, Aimagambetova G, Bapayeva G, Laganà AS, Chiantera V, Oppelt P et al. Reproductive and Obstetric Outcomes after UAE, HIFU, and TFA of Uterine Fibroids: Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2023;20(5):4480. https://doi.org/10.3390/ijerph20054480Test.; D’Asta M, Gulino FA, Ettore C, Dilisi V, Pappalardo E, Ettore G. Uterine Rupture in Pregnancy following Two Abdominal Myomectomies and IVF. Case Rep Obstet Gynecol. 2022;2022:6788992. https://doi.org/10.1155/2022/6788992Test.; Khaw SC, Anderson RA, Lui MW. Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids. Reprod Biomed Online. 2020;40(3):429–444. https://doi.org/10.1016/j.rbmo.2020.01.003Test.; Wise LA, Thomas L, Anderson S, Baird DD, Anchan RM, Terry KL et al. Route of myomectomy and fertility: a prospective cohort study. Fertil Steril. 2022;117(5):1083–1093. https://doi.org/10.1016/j.fertnstert.2022.01.013Test.; Хорольский ВА, Новикова ВА. Органосохраняющее лечение миомы матки как этап персонализированной прегравидарной подготовки. Лечение и профилактика. 2022;12(1):26–39. Режим доступа: https://www.elibrary.ru/gfhljjTest.; Стуклов НИ, Леваков СА, Сушинская ТВ, Митченкова АА, Ковальчук МО. Профилактика и лечение анемии у женщин репродуктивного возраста при гинекологических заболеваниях. Акушерство и гинекология. 2020;(3):218–226. https://doi.org/10.18565/aig.2020.3.218-226Test.; Синчихин СП, Магакян СГ, Синчихина ЕС, Магакян ГС. Алгоритм ведения пациенток с миомой матки в прегравидарном периоде. Вопросы гинекологии, акушерства и перинатологии. 2022;21(6):139–145. Режим доступа: https://www.elibrary.ru/vcuxzvTest.; Jeldu M, Asres T, Arusi T, Gutulo MG. Pregnancy Rate after Myomectomy and Associated Factors among Reproductive Age Women Who Had Myomectomy at Saint Paul’s Hospital Millennium Medical College, Addis Ababa: Retrospective Cross-Sectional Study. Int J Reprod Med. 2021:6680112. https://doi.org/10.1155/2021/6680112Test.; https://www.med-sovet.pro/jour/article/view/8174Test

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية